{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:26:01Z","timestamp":1759332361278,"version":"3.33.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023JDKP0059"],"award-info":[{"award-number":["2023JDKP0059"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023JDR0243"],"award-info":[{"award-number":["2023JDR0243"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Health Commission Program","award":["2020-111"],"award-info":[{"award-number":["2020-111"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>There is different administration routes of triamcinolone acetonide (TA) administration for macular edema, but the efficacy ranking remains unclear. The purpose of this study is to assess the efficacy of different administration routes of TA employed in macular edema. PubMed, Medline, Embase, and Cochrane Central Register of Controlled Trials were systematically searched for published articles comparing macular edema in patients with triamcinolone acetonide in different administration. The sparse network was evaluated using a random-effects model and consistency model within the Bayesian framework, utilizing the multinma package in R. The evidence was assessed based on the Grading of Recommendations. Assessment, Development, and Evaluation (GRADE) criteria. A total of 1138 citations were identified by our search, of which 20 RCTs enrolled 892 eyes. The network showed that intravitreal triamcinolone acetonide (IVTA) was associated with a statistically significant better best corrected visual acuity (BCVA) at the 12th week compared to placebo (MD: \u2212\u20090.15, 95% CI: \u2212\u20090.30 to \u2212\u20090.01, P\u2009&lt;\u20090.05), which was moderate-quality evidence. IVTA and suprachoroidal triamcinolone acetonide (SCTA) were both associated with a statistically significant reduction in central macular thickness (CMT) at the 12th week, which was moderate evidence. The probabilities of rankings and SUCRA demonstrated that sub-Tenon\u2019s infusion of triamcinolone acetonide (STiTA) might be the worst. SCTA and IVTA were proven to be the best administration routes for improving BCVA and reducing CMT. In addition, STiTA was less advisable than other administration routes of triamcinolone acetonide according to the rankings and SUCRA.<\/jats:p>","DOI":"10.1371\/journal.pone.0317782","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T19:17:09Z","timestamp":1737746229000},"page":"e0317782","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of different routes of triamcinolone acetonide administration on macular edema: A systematic review and network meta-analysis"],"prefix":"10.1371","volume":"20","author":[{"given":"Kexin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9213-1595","authenticated-orcid":true,"given":"Na","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"pone.0317782.ref001","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","article-title":"Mechanisms of macular edema: beyond the surface","volume":"63","author":"A Daruich","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"pone.0317782.ref002","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.3390\/ijms24119591","article-title":"Current treatments for diabetic macular edema","volume":"24","author":"T Tatsumi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0317782.ref003","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/08820538.2013.796394","article-title":"Surgical treatment for macular edema","volume":"29","author":"S Golan","year":"2014","journal-title":"Semin Ophthalmol"},{"issue":"Suppl 1","key":"pone.0317782.ref004","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.2337\/dc22-S012","article-title":"12. retinopathy, neuropathy, and foot care: standards of medical care in diabetes-2022","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","journal-title":"Diabetes Care"},{"issue":"6 Suppl","key":"pone.0317782.ref005","first-page":"S75","article-title":"Disease burden of neovascular age-related macular degeneration and diabetic macular edema","volume":"29","author":"A Almony","year":"2023","journal-title":"Am J Manag Care"},{"issue":"12","key":"pone.0317782.ref006","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/jamaophthalmol.2021.4395","article-title":"Intraocular pressure-related events after anti-vascular endothelial growth factor therapy for macular edema due to central retinal vein occlusion or hemiretinal vein occlusion: score2 report 16 on a secondary analysis of a randomized clinical trial","volume":"139","author":"AA Aref","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"pone.0317782.ref007","doi-asserted-by":"crossref","first-page":"824790","DOI":"10.3389\/fphar.2022.824790","article-title":"Steroid treatment in macular edema: a bibliometric study and visualization analysis","volume":"13","author":"Y Lin","year":"2022","journal-title":"Front Pharmacol"},{"issue":"11","key":"pone.0317782.ref008","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.4103\/ijo.IJO_1465_21","article-title":"Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema","volume":"69","author":"S Mohan","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"10","key":"pone.0317782.ref009","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/13543776.2019.1671353","article-title":"Agents for the prevention and treatment of age-related macular degeneration and macular edema: a literature and patent review","volume":"29","author":"CT Supuran","year":"2019","journal-title":"Expert Opin Ther Pat"},{"issue":"5","key":"pone.0317782.ref010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/APO.0000000000000312","article-title":"Diabetic macular edema management in Asian population: expert panel consensus guidelines","volume":"9","author":"J Chhablani","year":"2020","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"3","key":"pone.0317782.ref011","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000502041","article-title":"Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA)","volume":"242","author":"U Schmidt-Erfurth","year":"2019","journal-title":"Ophthalmologica"},{"issue":"1","key":"pone.0317782.ref012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.17-22259","article-title":"Pharmacology of corticosteroids for diabetic macular edema","volume":"59","author":"SM Whitcup","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"pone.0317782.ref013","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/0301-4738.25840","article-title":"Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice","volume":"54","author":"V Vedantham","year":"2006","journal-title":"Indian J Ophthalmol"},{"key":"pone.0317782.ref014","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"MJ Page","year":"2021","journal-title":"BMJ"},{"key":"pone.0317782.ref015","article-title":"Chapter 8: assessing risk of bias in a randomized trial","author":"J Higgins","year":"2020","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions"},{"key":"pone.0317782.ref016","doi-asserted-by":"crossref","first-page":"m3900","DOI":"10.1136\/bmj.m3900","article-title":"GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework","volume":"371","author":"R Brignardello-Petersen","year":"2020","journal-title":"BMJ"},{"key":"pone.0317782.ref017","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","article-title":"The GRADE Working Group clarifies the construct of certainty of evidence","volume":"87","author":"M Hultcrantz","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"pone.0317782.ref018","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2021.03.026","article-title":"GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings","volume":"137","author":"L Zeng","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"pone.0317782.ref019","unstructured":"Bayesian network meta-analysis of individual and aggregate data. R package version 0.1.3 version [cited 2022 Dec 12]. Available from: https:\/\/zenodo.org\/record\/7033094#.Y8QAllFByUk"},{"issue":"5","key":"pone.0317782.ref020","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1177\/0962280213500185","article-title":"A Bayesian network meta-analysis for binary outcome: how to do it","volume":"25","author":"T Greco","year":"2016","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"pone.0317782.ref021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1167","article-title":"Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis","volume":"7","author":"G van Valkenhoef","year":"2016","journal-title":"Res Synth Methods"},{"issue":"2","key":"pone.0317782.ref022","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"G Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"pone.0317782.ref023","first-page":"7947710","article-title":"A randomized trial comparing suprachoroidal and intravitreal injection of triamcinolone acetonide in refractory diabetic macular edema due to epiretinal membrane","author":"A Abdelshafy Tabl","year":"2022","journal-title":"J Ophthalmol"},{"issue":"10","key":"pone.0317782.ref024","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1167\/iovs.05-0297","article-title":"Intravitreal injection versus sub-Tenon\u2019s infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial","volume":"46","author":"MA Bonini-Filho","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"pone.0317782.ref025","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ophtha.2005.03.023","article-title":"Comparison of intravitreal versus posterior sub-Tenon\u2019s capsule injection of triamcinolone acetonide for diffuse diabetic macular edema","volume":"112","author":"JA Cardillo","year":"2005","journal-title":"Ophthalmology"},{"issue":"4","key":"pone.0317782.ref026","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4103\/1110-2098.149629","article-title":"Intravitreal versus subtenon injection of triamcinolone acetonide for diabetic macular edema","volume":"27","author":"AH Abd El-Razik","year":"2014","journal-title":"Menoufia Med J"},{"issue":"7","key":"pone.0317782.ref027","first-page":"1365","article-title":"Intravitreal injection of triamcinolone acetonide combined with retinal photocoagulation for cystoid macular edema associated with nonischemic central retinal vein occlusion","volume":"10","author":"J Feng","year":"2010","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"pone.0317782.ref028","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1167\/iovs.09-4400","article-title":"Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial","volume":"51","author":"MC Gillies","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"pone.0317782.ref029","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ajo.2004.12.087","article-title":"Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion","volume":"139","author":"K Hayashi","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"pone.0317782.ref030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3341\/kjo.2009.23.3.153","article-title":"Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema","volume":"23","author":"HY Lee","year":"2009","journal-title":"Korean J Ophthalmol"},{"issue":"6","key":"pone.0317782.ref031","first-page":"1289","article-title":"Efficacy and safety of combination treatment with triamcinolone acetonide retrobulbar injection and panretinal photocoagulation in diabetic macular edema","volume":"40","author":"S Li","year":"2014","journal-title":"J Jilin Univ Med Ed"},{"issue":"4","key":"pone.0317782.ref032","first-page":"749","article-title":"Subtenon vs intravitreal triamcinolone injection in diabetic macular edema, a prospective study in chinese population","volume":"30","author":"D Luo","year":"2014","journal-title":"Pak J Med Sci"},{"issue":"2","key":"pone.0317782.ref033","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ajo.2008.08.024","article-title":"Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial","volume":"147","author":"OO Maia","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"pone.0317782.ref034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000492135","article-title":"Phase II\/III clinical trial of sub-tenon injection of triamcinolone acetonide (WP-0508ST) for diabetic macular edema","volume":"241","author":"Y Ogura","year":"2019","journal-title":"Ophthalmologica"},{"issue":"3","key":"pone.0317782.ref035","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ajo.2008.09.011","article-title":"Comparison between intravitreal and orbital floor triamcinolone acetonide after phacoemulsification in patients with endogenous uveitis","volume":"147","author":"M Roesel","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"pone.0317782.ref036","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/jop.2014.0130","article-title":"Posterior Subtenon\u2019s capsule triamcinolone acetonide injection for the treatment of diabetic macular edema","volume":"31","author":"MA Saleh","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"key":"pone.0317782.ref037","first-page":"13","article-title":"Comparison between the effects of intravitreal and posterior subtenon injection of triamcinolone acetonide for treatment of diabetic macular edema","volume":"35","author":"MA Soliman","year":"2018","journal-title":"Benha Medi J"},{"issue":"4","key":"pone.0317782.ref038","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/IAE.0b013e3181c969b4","article-title":"Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema","volume":"30","author":"C Takata","year":"2010","journal-title":"Retina"},{"issue":"11","key":"pone.0317782.ref039","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1167\/iovs.08-1678","article-title":"Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema","volume":"49","author":"SS Wickremasinghe","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"pone.0317782.ref040","first-page":"435","article-title":"Effect of treatment for diabetic macular edema with triamcinolone acetonide using different methods of injection combined with laser photocoagulation","volume":"14","author":"LS Xu","year":"2014","journal-title":"Inter Eye Sci"},{"issue":"4","key":"pone.0317782.ref041","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000324714","article-title":"Intravitreal versus sub-tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema","volume":"225","author":"O Yalcinbayir","year":"2011","journal-title":"Ophthalmologica"},{"key":"pone.0317782.ref042","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2147\/OPTH.S351853","article-title":"Suprachoroidal versus intravitreal triamcinolone acetonide for the treatment of diabetic macular edema","volume":"16","author":"YG Zakaria","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"13 Suppl","key":"pone.0317782.ref043","first-page":"S243","article-title":"Microinjection via the suprachoroidal space: a review of a novel mode of administration","volume":"28","author":"T Ciulla","year":"2022","journal-title":"Am J Manag Care"},{"issue":"7","key":"pone.0317782.ref044","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ophtha.2020.01.006","article-title":"Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial","volume":"127","author":"S Yeh","year":"2020","journal-title":"Ophthalmology"},{"issue":"8","key":"pone.0317782.ref045","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1080\/09273948.2021.1954199","article-title":"Suprachoroidal CLS-TA with and without Systemic Corticosteroid and\/or Steroid-Sparing Therapy: a post-hoc analysis of the phase 3 PEACHTREE clinical trial","volume":"31","author":"PT Merrill","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"pone.0317782.ref046","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1080\/09273948.2023.2262015","article-title":"Safety and efficacy of CLS-TA by anatomic location of inflammation: results from the phase 3 PEACHTREE clinical trial","volume":"32","author":"M Shah","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"pone.0317782.ref047","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.18240\/ijo.2022.12.18","article-title":"A simple technique for suprachoroidal space injection of triamcinolone acetonide in treatment of macular edema","volume":"15","author":"D-D Zhang","year":"2022","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"pone.0317782.ref048","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12886-023-02808-5","article-title":"Suprachoroidal triamcinolone acetonide for the treatment of macular edema associated with retinal vein occlusion: a pilot study","volume":"23","author":"BM Ali","year":"2023","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"pone.0317782.ref049","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study","volume":"108","author":"RJ Antcliff","year":"2001","journal-title":"Ophthalmology"},{"issue":"2","key":"pone.0317782.ref050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bjo.86.2.247","article-title":"Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion","volume":"86","author":"PB Greenberg","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"pone.0317782.ref051","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","volume":"109","author":"A Martidis","year":"2002","journal-title":"Ophthalmology"},{"issue":"10","key":"pone.0317782.ref052","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.3390\/jcm12103475","article-title":"Retinal microvascular changes after intravitreal triamcinolone acetonide in diabetic macular edema","volume":"12","author":"F Kato","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"pone.0317782.ref053","first-page":"CD011599","article-title":"Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema","volume":"4","author":"H Mehta","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"pone.0317782.ref054","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10384-019-00710-6","article-title":"The effects of intravitreal triamcinolone acetonide in diabetic macular edema refractory to anti-VEGF treatment","volume":"64","author":"IH Hong","year":"2020","journal-title":"Jpn J Ophthalmol"},{"issue":"9","key":"pone.0317782.ref055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3928\/23258160-20170829-06","article-title":"High-dose decanted triamcinolone for treatment-resistant persistent macular edema","volume":"48","author":"IK Muftuoglu","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"1","key":"pone.0317782.ref056","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40662-021-00261-3","article-title":"Intravitreal corticosteroids for diabetic macular edema: a network meta-analysis of randomized controlled trials","volume":"8","author":"L Gao","year":"2021","journal-title":"Eye Vis (Lond)"},{"issue":"7","key":"pone.0317782.ref057","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3390\/biomedicines11071901","article-title":"The evolution of triamcinolone acetonide therapeutic use in retinal diseases: from off-label intravitreal injection to advanced nano-drug delivery systems","volume":"11","author":"LA Aceves-Franco","year":"2023","journal-title":"Biomedicines"},{"key":"pone.0317782.ref058","first-page":"52","article-title":"Intraocular distribution and targeting of triamcinolone acetonide suspension administered into the suprachoroidal space","volume":"55","author":"HF Edelhauser","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"pone.0317782.ref059","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12348-024-00386-1","article-title":"Risk factors for failing sub-Tenon\u2019s triamcinolone acetonide for uveitic macular edema","volume":"14","author":"AK Reddy","year":"2024","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"pone.0317782.ref060","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12886-020-01759-5","article-title":"Retrobulbar triamcinolone for inflammatory choroidal neovascularization in pregnancy","volume":"20","author":"E Maggio","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"pone.0317782.ref061","doi-asserted-by":"crossref","first-page":"e0245010","DOI":"10.1371\/journal.pone.0245010","article-title":"Intravitreal bevacizumab versus intravitreal triamcinolone for diabetic macular edema-Systematic review, meta-analysis and meta-regression","volume":"16","author":"M Abdel-Maboud","year":"2021","journal-title":"PLoS One"},{"issue":"12","key":"pone.0317782.ref062","doi-asserted-by":"crossref","first-page":"12467","DOI":"10.21037\/apm-21-3274","article-title":"Efficacy and safety of triamcinolone acetonide injection combined with laser photocoagulation in the treatment of diabetic macular edema: a systematic review and meta-analysis","volume":"10","author":"L Zhang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"pone.0317782.ref063","doi-asserted-by":"crossref","first-page":"696201","DOI":"10.3389\/fphar.2021.696201","article-title":"Conbercept for treatment of neovascular age-related macular degeneration and visual impairment due to diabetic macular edema or pathologic myopia choroidal neovascularization: a systematic review and meta-analysis","volume":"12","author":"P Zhou","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"pone.0317782.ref064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/erj.erj_15_20","article-title":"Efficacy of posterior Sub-Tenon\u2019s capsule injection compared to intravitreal injection of triamcinolone acetonide for treatment of diabetic macular edema","volume":"8","author":"MHG Ibrahim","year":"2021","journal-title":"Egypt Retina J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T19:17:59Z","timestamp":1737746279000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317782"}},"subtitle":[],"editor":[{"given":"Eleftherios Paschalis","family":"Ilios","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0317782","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]}}}